Alps Advisors Inc Mirum Pharmaceuticals, Inc. Transaction History
Alps Advisors Inc
- $15.7 Billion
- Q4 2024
A detailed history of Alps Advisors Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 38,822 shares of MIRM stock, worth $1.58 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,822
Previous 37,245
4.23%
Holding current value
$1.58 Million
Previous $1.45 Million
10.54%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
214Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$268 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$187 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$132 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$114 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$106 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.5B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...